Insider trading

Period: 12 months Type of trade: Sold × Plan: Discretionary × + Add filter Clear all
Views & alerts

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

23,346 decisions over 12 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

23,346 decisions over 12 months
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

23,346 decisions over 12 months Remove this filter
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

23,346 decisions over 12 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
23,346 decisions over 12 months Remove this filter
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
23,346 decisions over 12 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

23,346 decisions over 12 months
Stock
Insider
Type ?
Why it stands out
4 Sep 2026
Powell Lisa A. EVP and Chief Merch Officer
Sold at will
$701.00K 10,000 at 70.10
41.7%
Not planned
4 Sep 2026
Bos Teresa D. 10% owner
Sold at will
$682.79K 56,429 at 12.10
6.7%
Not planned
4 Sep 2026
Sold at will
$652.20K 2,000 at 326.10
1.9%
Not planned
4 Sep 2026
Cheng Chi Fung Chief Technology Officer
Sold at will
$644.30K 3,790 at 170.00
2.7%
Not planned
4 Sep 2026
Keating Michelle R Vice President
Sold at will
$610.72K 20,000 at 30.54
44.2%
Not planned
4 Sep 2026
Sold at will 15×
$583.91K 1,120 at 521.35
100%
Sold half or more
4 Sep 2026
Sold at will
$550.10K 10,000 at 55.01
64.8%
Sold half or more
4 Sep 2026
Sold at will
$526.05K 167,149 at 3.15
1.5%
Not planned
4 Sep 2026
Eglin Jon Stephen Chartering & Operations
Sold at will
$525.00K 25,000 at 21.00
8.3%
Not planned
4 Sep 2026
Marein-Efron Melanie Chief Financial Officer
Sold at will
$460.28K 5,700 at 80.75
33.5%
Not planned
4 Sep 2026
Ravin Seth A. President, CEO & Chairman · indirect
Sold at will
$449.96K 89,639 at 5.02
0.9%
Not planned
4 Sep 2026
Rizzuti Edward EVP, Corp Dev, IR & Secretary
Sold at will
$443.16K 2,537 at 174.68
31.2%
Not planned
4 Sep 2026
Melhem Elie President- APAC, M. East, Afr.
Sold at will
$394.07K 1,096 at 359.55
12.2%
Not planned
4 Sep 2026
DANIELS LESLIE B Director
Sold at will 2×
$357.00K 4,100 at 87.07
8.2%
Not planned
4 Sep 2026
Hansotia Eric P Chairman, President and CEO
Sold at will
$337.87K 2,604 at 129.75
0.8%
Not planned
4 Sep 2026
Erstad Dean Everett Senior VP Sales & Marketing
Sold at will
$327.18K 1,587 at 206.16
72.3%
Sold half or more
4 Sep 2026
Paladin Michael Shane Chief Customer & Rev Officer
Sold at will
$317.75K 307 at 1,035.01
11.1%
Not planned
4 Sep 2026
Ford Brandy SVP & Chief Accounting Officer
Sold at will 2×
$304.00K 5,293 at 57.43
34.8%
Not planned
4 Sep 2026
Carroll John A. VP & Chief Accounting Officer · indirect
Sold at will
$300.16K 1,365 at 219.90
28.0%
Not planned
4 Sep 2026
Phipps Chad F See remarks below.
Sold at will
$295.05K 3,000 at 98.35
4.4%
Not planned
4 Sep 2026
ZEVNIK PAUL A Director · indirect
Sold at will
$293.97K 35,000 at 8.40
49.2%
Not planned
4 Sep 2026
Lipesky Scott D. EVP and COO
Sold at will
$293.64K 2,000 at 146.82
1.4%
Not planned
4 Sep 2026
MPM BioVentures 2014, L.P. 10% owner · indirect
Sold at will
$273.74K 38,500 at 7.11
0.9%
Not planned
4 Sep 2026
MPM BIOVENTURES 2018, L.P. 10% owner · indirect
Sold at will
$273.74K 38,500 at 7.11
0.9%
Not planned
4 Sep 2026
Sold at will 15×
$262.76K 504 at 521.35
100%
Sold half or more
4 Sep 2026
Sold at will
$252.89K 3,100 at 81.58
11.8%
Not planned
4 Sep 2026
Budur Kumar CHIEF MEDICAL OFFICER
Sold at will
$230.91K 5,500 at 41.98
22.8%
Not planned
4 Sep 2026
CHANG FRED FACHING Director · indirect
Sold at will
$212.10K 13,582 at 15.62
0.4%
Not planned
4 Sep 2026
Cheng Marvin VP-Manufacturing, Secy
Sold at will
$193.50K 4,000 at 48.38
0.1%
Not planned
4 Sep 2026
Story Brooke Director
Sold at will
$187.27K 2,300 at 81.42
23.5%
Not planned
4 Sep 2026
Islam Nayaab See Remarks
Sold at will
$164.18K 24,554 at 6.69
0.3%
Not planned
4 Sep 2026
Stahl Stephanie Director
Sold at will
$155.79K 1,185 at 131.47
22.5%
Not planned
4 Sep 2026
Knutson Jeffrey Scott VP Finance, CFO, Secr & Trea
Sold at will
$137.22K 5,902 at 23.25
3.3%
Not planned
4 Sep 2026
Bennett Kelvin Eugene SVP Engineering
Sold at will
$132.89K 1,000 at 132.89
6.6%
Not planned
4 Sep 2026
COLLINS GARY S VICE CHAIRMAN · indirect
Sold at will
$128.53K 5,000 at 25.71
8.6%
Not planned
4 Sep 2026
Allen Frances L. Director
Sold at will
$117.25K 500 at 234.50
3.8%
Not planned
4 Sep 2026
Carlson Megan CAO and SVP, Finance
Sold at will
$100.80K 13,804 at 7.30
3.2%
Not planned
4 Sep 2026
Sudhir Srivastava Chairman and CEO · indirect
Sold at will
$100.00K 33,333 at 3.00
0.0%
Not planned
4 Sep 2026
Dolsten Mikael Director
Sold at will
$95.97K 634 at 151.38
11.4%
Not planned
4 Sep 2026
DILLON LARRY G EXECUTIVE CHAIRMAN
Sold at will
$95.07K 1,000 at 95.07
2.9%
Not planned
4 Sep 2026
Crone S Dustin PRESIDENT & CEO C&F FINANCE
Sold at will
$84.97K 900 at 94.41
9.7%
Not planned
4 Sep 2026
Wassil Jim EVP, Chief Scientific Ofc, COO
Sold at will
$84.46K 1,381 at 61.16
0.9%
Not planned
4 Sep 2026
RUHLMAN RANDALL M 10% owner
Sold at will
$56.81K 142 at 400.04
0.0%
Not planned
4 Sep 2026
Sold at will
$52.83K 1,000 at 52.83
4.8%
Not planned
4 Sep 2026
BONTA DIANA M Director
Sold at will
$48.49K 546 at 88.80
3.2%
Not planned
4 Sep 2026
Sold at will
$43.63K 1,531 at 28.50
100%
Sold half or more
4 Sep 2026
Rivard Bill John Chief Accounting Officer
Sold at will
$41.25K 12,500 at 3.30
21.6%
Not planned
4 Sep 2026
Smither John W Director
Sold at will
$40.51K 1,600 at 25.32
15.4%
Not planned
4 Sep 2026
Sold at will
$36.97K 6,293 at 5.88
10.5%
Not planned
4 Sep 2026
Chin Peter Scott Chief Medical Officer
Sold at will
$36.87K 1,654 at 22.29
0.8%
Not planned
Showing 1,551–1,600 of 23,346. ← Newer Page 32 of 467 Older →